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Abstract
Cancer is one of the most leading causes of death worldwide. Morin-
da citrifolia was reported to have antitumor effects. Cisplatin (CDDP), 
Doxorubicin (DOX) and Cyclophosphamid (CPA) are the known effecti-
ve chemotherapeutics, despite of having several side effects. This stu-
dy evaluated antitumoral and oxidative effects of the aqueous extract 
of the fruit of M. critrifolia (AEMC) (15, 30, 60 and 120 µg/mL) in 
comparision to CDDP (1 and 5 μg/mL), CPA (20 μg/mL), DOX (2 μg/mL) 
and CPA + DOX (20:2 μg/mL) in Sarcoma 180 cells and Saccharomyces 
cerevisiae, respectively. Cytogenetic damage and DNA fragmentation 
were evaluated with cytokinesis-block micronucleus assay and comet 
assay, respectively. In addition, S. cerevisiae strains were used in oxida-
tive damage evaluation. AEMC induced cytogenetic damage with the 
increased formation of micronuclei, nuclear buds and nucleoplasmic 
bridges compared to the antineoplastics tested. AEMC at 120 µg/
mL induced significant (p<0.05) DNA damage in Sarcoma 180 cells 
similar to the CDDP, as well as oxidative damage in S. cerevisiae strain 
deficient in mitochondrial superoxide dismutase (Sod2∆) and cytosolic 
catalase (Cat1∆). The bioactive compounds present in AEMC such as 
gallic, caffeic, chlorogenic, ellagic acid and rutin might be responsible 
for AEMC’s antitumoral activity.
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Introduction
The cancer is one of the most prevalent causes of 
mortality worldwide [1]. The major problem in the 
treatment of malignancies involved molecular gene-
tic and epigenetic mechanisms in the development 
of resistant phenotypes [2], characterizing cancer is 
a heterogeneous genetic disease with several alte-
rations in different cellular signaling pathways [3].
Chemotherapy is usually well tolerated, but in-
duces necrosis predictive for metastasis risk [4]. 
The antineoplastics, such as alkylating agents po-
lyfunctional, antimetabolites, antibiotics and mitotic 
inhibitors induce apoptosis, avoiding inflammatory 
processes arising from necrosis [5]. Cisplatin (CDDP) 
induces renal cell death that have been fully ascri-
bed to its ability to generate unrepairable DNA le-
sions, hence inducing cellular senescence or apopto-
sis by mitochondrial pathway [6]. Doxorubicin (DOX) 
is one of the most effective anticancer drugs acting 
by the inhibition of topoisomerase II, although, its 
clinical use is limited due to adverse effects, such as 
cardiotoxicity induced by lipid peroxidation [7] and 
oxidative stress [8]. Otherwise, Cyclophosphamide 
(CPA), a nitrogen mustard compound, is a bifunctio-
nal alkylating agent, generating DNA adducts, DNA 
cross-links, and single and double-strand DNA 
breaks in dividing cells (chromosomal aberrations) 
[9]. In this context, chemotherapy remains the most 
important line of defense against hematological 
malignancies and aggressive forms of solid tumors. 
Plant compounds have importantly contributed to 
the discovery of new naturally occurring anticancer 
agentes [10].
The tropical plant Morinda citrifolia Linn. (Ru-
biaceae) commonly known as “Noni”, is widely 
distributed in Micronesia, Hawaii, Australia, and 
Southeast Asia [11]. M. citrifolia has been used in 
folk remedies and is reported to have a broad range 
of therapeutic effects, including antibacterial, anti-
viral, antifungal, antitumor, analgesic, hypotensive, 
anti-inflammatory, and immune enhancing effects 
[12]. Since alternative therapies from plants to fight 
cancer have presented good examples, this work 
compared antitumoral and oxidative effects of the 
aqueous extract from M. citrifolia fruits (AEMC) in 
Sarcoma 180 and Saccharomyces cerevisiae cells, 
respectively.
Methods
Chemicals
The antineoplastics agents Cisplatin (CDDP), Cyclo-
phosphamide (CPA) and Doxorubicin (DOX) were 
purchase from Eurofarma® Laboratories and dis-
solved in sterile saline (0.9% NaCl). The combi-
nation of both antineoplastic agentes Doxorubicin 
+ Cyclophosphamide (AC) were prepared in the 
same way.
Collection and extraction of plant material
Fruits of M. citrifolia were collected in 2014 in the 
municipality of Altos, Piauí, Brazil, (05° 02’ 20” S - 
latitude, 42° 27’ 39” O - longitude) at 187 m above 
sea level. The botanical identification was held at 
Center for Environmental Sciences of Tropic Eco-
tonal Northeast, Teresina, Piauí (volcher number: 
21644). After collection, the fruits were dried in a 
forced air oven for 8 days at a maximum tempe-
rature of 45 °C (± 1 °C). Then, they followed by 
course grinding and were preserved in a amber 
glass.
HPLC analysis
High performance liquid chromatograph (HPLC) 
analyses for determination of flavonoids and pheno-
lic compounds were performed on a Waters 2695 
liquid chromatograph equipped with autosampler 
and a variable wavelength UV/VIS detector (Waters 
2487 Detector Dual Absorbance, 190-700 nm). 
Columns: Waters Spherisorb ODS2 (5 µm, 4.6x250 
mm). The mobile phases consisted of acetonitrile (A) 
HPLC grade purchased and 0.1% H3PO4 aqueous 
solution (B, filtered using a Millipore system). The 
following were the gradient conditions: 5% (A); 
InternatIonal archIves of MedIcIne 
sectIon: toxIcology & therapeutIcs
ISSN: 1755-7682
2016
Vol. 9 No. 96
doi: 10.3823/1967
© Under License of Creative Commons Attribution 3.0 License 3
15% (A) for 10 min; 35% (A) for 40 min; 100% 
(A) for 15 min and 5% (A) for 5 min. Total run time 
was 70 min at a flow rate of 1.8 mL/min. Injection 
volumes were 20 µL. The AEMC was solubilized in 
acetonitrile (30%) HPLC grade purchased and 0.1% 
H3PO4 aqueous solution (70%).
Primary culture of Sarcoma 180 cells
Ascite-bearing female mice between 7 and 9 days 
(post-treated) were sacrificed by cervical disloca-
tion and a suspension of Sarcoma 180 (S180) cells 
was harvested from the intraperitoneal cavity under 
aseptic conditions. The suspension was centrifuged 
at 500 X g for 5 min to obtain a cell pellet and was-
hed three times with RPMI medium. Cell concentra-
tion was adjusted to 0.5 x 106 cells/mL in supple-
mented RPMI 1640 medium with 20% foetal bovi-
ne serum, 2 mM glutamine, 100 U/mL penicillin and 
100 μg/mL streptomycin (Gibco, Grand Island, NY), 
and incubated with CDDP (1 and 5 μg/mL), DOX (2 
μg/mL), CPA (20 μg/mL), DOX + CPA at same con-
centration (2:20 μg/mL) and AEMC (15, 30, 60 and 
120 μg/mL) for 72 h at 37 ºC with 5% CO2. The 
protocols were approved by the Ethical Committee 
on Animal Research (Process No. 081/2014) and 
followed the Brazilian (Colégio Brasileiro de Experi-
mentação Animal - COBEA) and International Stan-
dards on the care and use of experimental animals 
(Directive 2010/63/EU of the European Parliament 
and of the Council). 
Trypan blue exclusion test
Cell viability was analyzed by the application of 
Trypan blue exclusion test according to Renzi et al. 
[13]. After 72 h, 10 μL of Trypan Blue were added 
to 90 μL of S180 cell suspension from each culture 
and analyzes were performed under an optical mi-
croscope using Neubauer chamber.
Cytokinesis-Block Micronucleus Assay 
(CBMN)
For this study, criteria for the identification of binu-
cleate cells and CBMN assay parameters are des-
cribed by Fenech et al. [14]. S180 cells suspension 
(0.5 x 106/mL) was added in supplemented RPMI 
1640 medium as described above and phytohema-
gglutinin A (Gibco, Grand Island, NY). Then, each 
24-well plate was treated as previously mentioned. 
Cells were incubated for 44 h at 37ºC with 5% 
CO2. After incubation, 6 μg/mL of cytochalasin B 
(Sigma, St. Louis, MO) was added to the cultures. 
Plates were maintained at incubator for additional 
28 h. At the end of these two incubation pha-
ses, the cultures were centrifuged at 800 rpm for 
5 minutes. Then, the supernatant was removed 
and cell pellets were gently agitated with 5 mL 
of fixing solution (methanol: acetic acid 5:1). After 
centrifugation and repeating fixing processes, the 
supernatant was discarded and 2 to 4 drops of 
cell suspension was dripped on slides, which were 
stained with Giemsa 5%. The previously coded sli-
des were examined in a blind test with an optical 
microscope at magnification of 100X and a total 
of 1000 cells/slide in duplicate was analysed for 
cytogenetic damage. 
Analyzes of DNA damage by comet assay
The comet assay was performed according to Speit 
and Rothfuss [15]. The slides were previously coa-
ted with a layer of agarose with normal melting 
point (NMPA; 0.75%) in phosphate buffered saline 
(PBS; pH 7.4) and stored in a darkroom, wet at 
4°C until test commenced (24 h). After incubation 
in same concentrations described above, 10 µL of 
S180 cell suspension were added to 90 µL of low 
melting point agarose (LMPA; 1.5%) at 35°C, the 
mixture was added to NMPA pre-coated slides and 
covered with cover slips. After solidification, sli-
des were immersed in lysis solution (10% DMSO, 
1% Triton X-100 mM Tris, 2.5 M NaCl, 100 mM 
EDTA, pH 10.0 to 10.5) for 72 h at 4°C. After the 
elapsed time, slides were then rinsed with DW, 
placed horizontally in a electrophoretic tank and 
covered with fresh electrophoresis buffer (0.0075 
M EDTA 1 mM, pH 13) for 20 min. Electrophoresis 
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was performed for 15 min at 300 mA and 25 V 
then followed by neutralization (400 mM Tris; pH 
7.5), fixation (15% v/v trichloroacetic acid, 5% v/v 
of zinc sulfate, 5% glycerol), washing with DW fo-
llowing to over-night drying at 18°C. The gels were 
then rehydrated for 5 min in DW and stained for 
15 min (37°C) with staining solution {1 part of so-
lution B (0.2% v/v ammonium nitrate, 0.2% silver 
nitrate v/ v, 0.5% v/v tungstosalisilic acid, 0.15% 
v/v formaldehyde, 5% v/v sodium carbonate) and 
3 part solution A (sodium carbonate to 5%)}. Stop 
solution was prepared with a solution of 1% acetic 
acid gels and subjected to dry at room tempe-
rature. Finally, a total of 100 cells were analyzed 
randomly per treatment. Two parameters were 
considered, such as index of damage (ID; 0-400) 
and frequency of damage (FD; 0-100%). For the 
calculation of identity, the cells were visually clas-
sified into five categories according to the size of 
comet tails (0 = no tail, 4 = maximum length of 
the tail), which resulted in a DNA damage score for 
each sample and hence for each group. Frequency 
of damage (FD) in percentage was calculated for 
each sample based on the number of cells with 
tails compared to damaged cells with zero (0). All 
slides were coded for blind analysis. 
Oxidative damage in Saccharomyces 
cerevisiae cells
For oxidative studies, wild-type strain EG103 
(SOD) S. cerevisiae and isogenic strains: deficient 
strains in cytosolic (Sod1∆) and mitochondrial 
superoxide dismutase (Sod2∆), double mutant 
(Sod1∆Sod2∆), catalase (Cat1∆), and cytosolic su-
peroxide dismutase + catalase (Cat1∆Sod1∆) were 
used and kindly provided by E.B. Gralla (Univer-
sity of California, Los Angeles, Los Angeles, CA). 
The strains were cultured in YEL medium (yeast 
extract 0.5%, 2% of Bacto-peptone and 2% of 
glucose) at 28°C in an orbital stirrer until it rea-
ched the stationary growth phase [16]. Cells in 
suspension were seeded from the center to the 
edge of a Petri dish in a continuous cycle on both 
sides, containing in the center of plate a sterile 
filter paper disk which received CDDP (1 and 5 
µg/mL), CPA (20 µg/mL), DOX (2 µg/mL), DOX + 
CPA (AC) (2:20 µg/mL) and AEMC (120 µg/mL). 
After 48 h of incubation at 30°C, the zones of 
inhibition growth were measured in millimeters 
(mm). The assays were performed in duplicate. 
Statistical analysis
In order to determine differences among treatments, 
data expressed as mean ± standard error of the 
mean (S.E.M.) were compared by one-way analysis 
of variance (ANOVA) followed by the Tukey test (p< 
0.05) using the Graphpad program (Intuitive Soft-
ware for Science, San Diego, CA). All studies were 
carried out in duplicate represented by independent 
biological evaluations. 
Results
HPLC analysis
The correlation of chromatographic peaks was 
achieved by comparing of experimental reten-
tion times (tR) with reference standards (Table 
1). All chromatographic preliminary phytochemi-
cal analysis of AEMC were carried out in tripli-
cate at room temperature and revealed phenolic 
compounds (gallic acid, chlorogenic acid, caffeic 
acid, ellagic acid and rosmarinic acid) and flavo-
noid (rutin) with the following tR: 3,4,5-trihydro-
xybenzoic acid(1) tR= 5 min; (1S,3R,4R,5R)-3-[(E)-
3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-
trihydroxycyclohexane-1 carboxylic acid (2) tR = 
14,9 min; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic 
acid (3)tR= 15,1 min; 2-(3,4-dihydroxyphenyl)-5,7-
dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-
[[(2R,3R,4R,5R,6S)-3,4,5 trihydroxy-6-methyloxan-
2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one (4)tR 
= 32.5 min; 2,3,7,8-Tetrahydroxy-chromeno[5,4,3-
cde]chromene-5,10-dione (5)tR = 35 min; (2R)-
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Table 1. HPLC analysis of aqueous extract of the fruit of Morinda citrifolia.
Compounds Chemical structures Retention time (tR)
Gallic acid 87.50
Chlorogenic acid 62.50
Caffeic acid 68.75
Rutin 62.50
Ellagic acid 81.25
Rosmarinic acid 87.50
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3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydro-
xyphenyl)prop-2-enoyl] oxypropanoic acid (6)tR = 
37.5 min. 
Cell viability
S180 cells viability was evaluated after 72 h following 
ex vivo exposure to antineoplastics and AEMC. S180 
cells treated with CDDP (1 and 5 µg/mL), CPA, DOX, 
AC and AEMC (30, 60 and 120 µg/mL) showed cell 
viability reduction (48.7 ± 2.5, 39.2 ± 1.5, 39.5 ± 
2.1, 45.5 ± 2.5, 38.5 ± 3.6, 54 ± 2.3, 53.7 ± 2.5 
and 50.7 ± 1.3, respectively) when compared with 
untreated cells (64.5 ± 3.5) (Figure 1, p<0.05).
Apoptosis and necrosis induced by 
antineoplastics and AEMC in S180 cells
CDDP (1 and 5 µg/mL), CPA, DOX, AC and AEMC 
(30, 60 and 120 µg/mL) induced apoptosis in S180 
cells (444 ± 40.2, 612 ± 103.2, 312 ± 25.4, 283 
± 6.3, 553 ± 18.3, 324.5 ± 66.5, 367.5 ± 67.1 
and 562 ± 55.1, respectively) in comparison with 
negative control (42.5 ± 6.3) and AEMC at 60 and 
120 µg/mL produced similar results to the antican-
cer agents (Figure 2, p<0.05). Meanwhile, all anti-
neoplastics substances also induced the arising of 
necrosis figures [75 ± 7.1, 81.5 ± 3.5, 107 ± 10.6, 
76.5 ± 4.9, 91 ± 8.5, 57.5 ± 10.6, 58 ± 16.9 for 
CDDP (1 and 5 µg/mL, CPA, DOX, AC and AEMC 
(60 and 120 µg/mL) respectively (p<0.05)], though 
these findings were not in lower concentrations of 
AEMC (p>0.05). 
Nuclear abnormalities induced by 
antineoplasics and AEMC in S180 cells
Micronucleus were statistically more found at 5 µg/
mL of CDDP (39.4 ± 1.5), at 120 µg/mL of AEMC 
(21.5 ± 2.1) and in sarcoma cells treated with DOX 
(14.2 ± 1.5) and with the association of AC (19.2 
± 2.8) when compared to the negative group (2.2 
± 1.4) (Figure 3). On the other hand, only CDDP 
(5 µg/mL) and AEMC at concentration of 120 µg/
mL induced significant increasing of nucleoplasmic 
bridges (25.3 ± 7.1 and 18.5 ± 2.1) (p<0.05). 
Once again, CDDP (1 and 5 µg/mL), CPA and 
DOX + CPA (AC) also increased the number of chro-
mosomal abnormalities (21.5 ± 4.9, 49.5 ± 3.5, 19.5 
± 2.1 and 21.4 ± 1.5). However, only the highest 
concentration of AEMC was able to induced the 
formation of nuclear buds (39.5 ± 0.7) (Figure 4, 
p<0.05).
Figure 1:  Effect of aqueous extract of fruit of 
M. citrifolia (AEMC) on Sarcoma 180 
cell viability determined by trypan blue 
staining after 72 h of incubation. (A) 
Number of viable cells; (B) number of 
non-viable cells; negative control (NC). 
Cisplatin (CDDP), Cyclophosphamide 
(CPA) 20 µg/mL, Doxorubicin (DOX) 
2 μg/mL and Doxorubicin + Cyclo-
phosphamide (AC) 20:2 µg/mL was 
used as positive control. Results are 
expressed as mean ± standard error 
of mean (SEM) from three independent 
experiments. *p<0.05 compared to 
control by ANOVA followed by Tukey 
test.
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Figure 2:  Cytotoxicity in Sarcoma 180 cells trea-
ted with aqueous extract of fruit of M. 
citrifolia (AEMC). NC: negative control. 
CDDP: cisplatin. CPA: cyclophosphami-
de (25 µg/mL). DOX: doxorubicin (2 µg/
mL). AC: Doxorubicin + Cyclophospha-
mide (2:20 µg/mL). *p<0.05 compared 
to the negative control by ANOVA fo-
llowed by Tukey test.
Figure 4:  Chromosomal abnormalities in Sarcoma 
180 cells treated with aqueous extract 
of fruit of Morinda citrifolia (AEMC). 
NC: negative control. CDDP: cispla-
tin. CPA: cyclophosphamide (25 µg/
mL). DOX: doxorubicin (2 µg/mL). AC: 
doxorubicin + cyclophosphamide (2:20 
µg/mL). *p<0.05 compared to the ne-
gative control by ANOVA followed by 
Tukey test.
Figure 3:  Mutagenicity in Sarcoma 180 cells trea-
ted with aqueous extract of fruit of M. 
citrifolia (AEMC). NC: negative control. 
CDDP: cisplatin. CPA: cyclophosphami-
de (25 µg/mL). DOX: doxorubicin (2 µg/
mL). AC: Doxorubicin + Cyclophospha-
mide (2:20 µg/mL). MNBN: micronu-
cleated binucleated cell. *p<0.05 com-
pared to the negative control by ANO-
VA followed by Tukey test.
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DNA damage induced by antineoplastics 
and AEMC in S180 cells
All concentrations of the AEMC increased the ID 
after 72 h of incubation (90 ± 15.5, 113 ± 27.5, 
122 ± 1.4, 147 ± 4.2 and 216 ± 9.1 for 5, 15, 30, 
60 and 120 µg/mL, respectively) (Figure 5, p<0,05) 
when compared to negative control (21.5 ± 5.6). 
Meanwhile, the positive control CDDP presented 
ID values of 282 ± 47.5 and 329 ± 43.8 for 1 and 
5 µg/mL, respectively. Regarding to FD, CPPD also 
caused significant increasing (66.5 ± 4.9 and 89.5 ± 
7.7, respectively) and only the lowest concentration 
of the AEMC did not induce FD increasing (60.2 ± 
5.8, p>0.05) (Figure 5).
Evaluation of oxidative damage induced 
by antineoplastics and AEMC in S. 
cerevisiae strains
All antineoplastics tested (CDDP, CPA, DOX and AC) 
induced oxidative damage in S. cerevisiae strains 
(SODWT, Sod1∆, Sod2∆, Sod1∆Sod2∆, Cat1∆ and 
Cat1∆Sod1∆). On the other, AEMC at 120 µg/mL 
induced oxidative damage only in the strain with 
mutation for mitochondrial superoxide dismutase 
(Sod2∆) and catalase (Cat1∆) (Table 2).
Figure 5:  Genotoxicity in Sarcoma 180 cells trea-
ted with aqueous extract of fruit of M. 
citrifolia (AEMC). NC: negative control. 
CDDP: cisplatin. *p<0.05 compared 
to the negative control by ANOVA fo-
llowed by Tukey test.
Tabl 2.  Inhibition growth induced by antineoplastics and aqueous extract of fruit of M. citrifolia (AEMC) 
in Saccharomyces cerevisiae strains.
Treatments
Strains
SODWT Sod1∆ Sod2∆ Sod1ΔSod2Δ Cat1∆ Sod1ΔCat1Δ
Saline 0.9% 2.2 ± 0.9 2.7 ± 1.0 3.0 ± 0.8 3.0 ± 0.8 2.5 ± 0.5 2.2 ± 1.0
H2O2 10 mM 21.2 ± 3.5* 22.1 ± 2.2* 20.5 ± 3.1* 20.8 ± 3.5* 22.5 ± 2.1* 21.4 ± 3.2*
CPA 20 µg/mL 23.5 ± 1.3* 27.5 ± 1.7* 34.2 ± 3.0* 35.7 ± 1.0* 36.2 ± 1.2* 34.2 ± 1.0*
DOX 2 µg/mL 10.7 ± 2.2* 10.2 ± 1.2* 11.3 ± 1.4* 9.5 ± 2.0* 12.2 ± 1.5* 10.4 ± 1.6*
AC 20:2 µg/mL 10.5 ± 2.0* 10.2 ± 0.8* 11.2 ± 1.7* 10.4 ± 1.4* 10.2 ± 2.0* 11.2 ± 1.0*
CDDP 1 µg/mL 6.0 ± 1.4* 4.7 ± 1.2* 10.2 ± 2.4* 6.5 ± 2.5* 8.5 ± 2.7* 6.7 ± 2.5*
CDDP 5 µg/mL 9.2 ± 1.5* 9.2 ± 2.5* 9.5 ± 2.5* 10.5 ± 2.6* 9.5 ± 2.5* 11.4 ± 2.5*
AEMC 120 µg/mL 6.5 ± 1.7 5.7 ± 1.0 8.5 ± 1.2* 6.4 ± 1.4 10.2 ± 2.0* 7.2 ± 1.0
#: values represent mean ± standard error of inhibition growth of S. cerevisiae strains. H2O2: hydrogen peroxide. 
CPA: Cyclophosphamide. DOX: Doxorubicine. AC: Doxorubicin + Cyclophosphamide. 
CDDP: cisplatin. ANOVA followed by Tukey test. *p<0.05 compared to Saline.
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Discussion
Cancer is represented by a pool of diseases related 
to the accumulation of multiple genetic changes 
that leads to genetic instability (DNA damage) and 
repair failures and they have been associated with 
the diagnosis and prognosis of neoplasms. Such 
instability can be mediated through chromosomal 
changes, that can be detected by, cytogenetical tec-
niques [17]. Assays as CBMN, Single Cell Gel Elec-
trophoresis and oxidative analyzes in S. cerevisiae 
strains have been proposed as biomarkers to assess 
cytogenetic alterations and measure DNA damage 
[18].
Primary cultures of tissues that preserve the ori-
ginal tumor microenvironment injected into mice 
has been used as models of human sarcomas [19], 
allowing the understanding of the molecular bio-
logy of cancer and cellular changes after exposu-
re to antiproliferative agents. Some tools, such as 
Cytokinesis-Block Micronucleus Assay (CBMN), a 
multi-endpoint assay that measures chromosomal 
damage; micronuclei (MN), reflecting chromoso-
me breaks; nucleoplasmic bridges (NPB), reflecting 
chromosomal rearrangements and nuclear buds 
(NBUD), reflecting gene amplification, along with 
other cellular events such as apoptosis and necrosis 
[14] are often used to evaluate pharmacological and 
toxicological effects of bioactive natural and synthe-
tic compounds in cellular models.
S180 cells provide a paradigm to identify unknown 
pharmacogenetic variants associated with drug-in-
duced cytotoxicity [20]. Herein, all chemotherapics 
used (CDDP, CPA, DOX, AC) and AEMC induced 
apoptosis, necrosis and reduced cell viability of sar-
coma 180 cells.
CDDP is capable to induce adduct formation 
effects and peculiar DNA-depentent functions, in-
cluding inhibition of replication and transcription, 
cell cycle arrest, and DNA damage that can lead to 
the cellular death and apoptosis, thus may followed 
by mutations [21]. Our results suggest that genetic 
factors involved in cytotoxicity also contribute to 
cisplatin-induced apoptosis. CDDP have been fu-
lly ascribed to its ability to generate unrepairable 
DNA lesions, hence inducing either a permanent 
proliferative arrest known as cellular senescence 
or apoptosis induction by mitochondrial pathway 
[22].
CPA is metabolically activated by the enzyme 
CYP2B6 and induced cell death via formation of 
DNA adducts by it’s active metabolite, phosphora-
mide mustard. These adducts are the most physio-
logically relevant because of their ability to block 
the replication of DNA and its association with 
cytotoxicity [23]. These DNA damages presented 
as nuclear abnormalities, such as micronuclei and 
formation of nuclear buds, were also found after 
treatment with CDDP (5 µg/mL), AEMC (120 µg/
mL), DOX and with the association of AC. Howe-
ver, only CDDP (5 µg/mL) and AEMC (120 µg/mL) 
induced significant increasing of nucleoplasmic 
bridges. Moreover, all concentrations of the AEMC 
increased the ID and FD after 72h of incubation, 
but only the lowest concentration did not induce 
FD increasing.
Cytotoxicity is a broad phenotype in which anti-
tumor effects may include the induction of apopto-
sis as seen with AEMC-Sarcoma treated cells. Some 
compounds presented in the AEMC, as the chloro-
genic acid (CGA), a family of polyphenolic esters, 
has been attributed in the amplification antitumor 
effects of 5-FU in human hepatocarcinoma cells 
by inhibition of extracellular signal-regulating ki-
nases. Other compounds also found in the AEMC, 
such as gallic, caffeic and ellagic acids have also 
been reported as cytotoxic apoptotic mechanisms. 
Gallic acid shows cytotoxic effects due to the pre-
sence of phenolic hydroxyl groups and carboxyl 
groups which may involve the specific cytotoxici-
ty between normal and tumor cells. Moreover, it 
decreases cell viability in a dose dependent man-
ner in DU145 and 22Rv1 cell lines by induction 
of apoptosis-related mechanisms [24]. Meanwhile, 
caffeic acid has been related to induction of cell 
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cycle arrest and apoptosis, protein kinases changes 
and inhibition of COX-2 activity [25] and ellagin 
acid induces apoptosis in human pancreatic ade-
nocarcinoma and hepatocarcinoma (HepG2) cells 
[26], sugesting mechanism involving mitochondrial 
membrane depolarization, release of protein C and 
caspases activation [27], activation of transcription 
factors and anti-apoptotic proteins dysregulation 
[28].
In a similar way, the flavonoid rutin also plays an-
titumor activity by induction of DNA damage in cells 
mutant for BRCA gene, cell cycle arrest (G2/M) in 
neuroblastoma cell lines by apoptosis-inducing me-
chanism, as well as regulation of gene expression 
suppressing tumor [29]. These are major bioactive 
constituents of AEMC responsible for various phar-
macological activities [30].
Necrosis was also identified in antineoplastics- 
and AEMC-sarcoma treated cells. In toxic stimulus 
analyzes, higher doses regularly develops concomi-
tant features of apoptosis and necrosis. Under such 
conditions, severity and not specificity of the sti-
mulus selectively determines how cell death occurs. 
If the necrosis prevails, early lesions on the plas-
ma membrane occur instead of cell shrinking [21]. 
Therefore, depending on the concentration used, 
many different processes may be influenced and/or 
altered, suggesting that dose-dependent regulation 
of cellular process reflects signalization triggered by 
bioactive compounds as stated here and by others. 
For example, previous studies with the diterpenoid 
casearin X also reported characteristics of apoptosis 
or secondary necrosis [31].
Micronuclei, biomarkers of genotoxic events and 
chromosomal instability were induced by AEMC 
(120 µg/mL), while the other nuclear abnormality, 
such as NPB, were produced by AECM and CDDP. 
The MN is frequently originated during anaphase 
from lagging acentric chromosome or chromatid 
fragments caused by misrepair of DNA breaks or 
unrepaired DNA breaks. Mal-segregation of whole 
chromosomes at anaphase may also lead to MN 
formation as a result of hypomethylation of re-
peat sequences in centromeric and pericentromeric 
DNA, defects in kinetochore proteins or assem-
bly, dysfunctional spindle and defective anaphase 
checkpoint genes. NPB originates from the dicen-
tric chromosomes, may occur due to misrepair of 
DNA breaks, telomere end fusions, and could also 
be observed when defective separation of sister 
chromatids at anaphase due to failure of deca-
tenation. NBUD represents the process of elimi-
nation of amplified DNA, DNA repair complexes 
and possibly excess chromosomes from aneuploid 
cells [14].
The yeast S. cerevisiae also provides a power-
ful experimental instrument for the study of drugs’ 
effect on eukaryotic cells [32]. Herein, oxidative da-
mage in S. cerevisiae point out that the AEMC (120 
µg/mL) induced oxidative damage similar to CDDP, 
DOX and AC at the concentrations tested to the 
strains Sod2∆ and Cat1∆. Hung et al. [33] have su-
ggested that caffeic acid, presented in AECM, redu-
ces mitochondrial membrane potential and induces 
apoptosis [34].
CDDP-induced oxidative stress is thought to be 
mediated by several mechanisms which include mi-
tochondrial dysfunction and GSH depletion [35]. 
Oxidative damage has been observed in vivo fo-
llowing exposure to CDDP in several tissues, sugges-
ting a role for oxidative stress in the pathogenesis of 
CDDP-induced dose-limiting toxicities. CDDP indu-
ced a mitochondrial-dependent ROS response that 
significantly enhanced the cytotoxic effect caused 
by DNA damage. However, ROS generation is inde-
pendent of the amount of CDDP-induced DNA da-
mage [36]. CDDP has been used in studies on drug 
mechanisms in yeast. Studies in S. cerevisiae and S. 
pombe have focused on the toxic effects of CDDP in 
DNA repair mutants and the mechanisms of repair 
of CDDP-induced DNA lesions [37]. Similarly, CPA 
is widely used in the treatment of tumors through 
production of ROS, which play an important role 
in cytotoxicity-mediated apoptosis [38]. DOX indu-
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ces cardiotoxicity by lipid peroxidation [7] caused by 
oxidative stress [8].
Despite of these genotoxic effects, M. citrifolia 
has been used in traditional therapies against several 
chronic diseases, including cancer. Damnacanthal, a 
compound isolated from M. citrifolia, increases anti-
tumorigenic activity in human colorectal cancer cells 
[39]. Futhermore, pre-clinical studies have suggest 
that Noni may have antitumor proper¬ties due to 
the immune system stimulating using macrophages, 
natural killer and T cells dependent ways [40].
It is likely that chemicals presented in AECM, such 
as gallic acid, chlorogenic acid, caffeic acid, ellagic 
acid and rosmarinic acid and rutin, are involved in 
the cytotoxicity on sarcoma and S. cerevisiae mu-
tants cells, by direct ou indirect (oxidative) DNA da-
mages, leading to apoptosis. In vitro and in vivo 
investigations are in progress with sarcoma 180 mo-
dels to detail the mechanisms(s) of action.
Conclusion
The aqueous fruit extract of Morinda critrifolia 
(AEMC) induced cytogenetic damages with increa-
sing in the formation of micronuclei, nuclear buds 
and nucleoplasmic bridges like the antineoplastics, 
Cisplatin, Cyclophosphamide and Doxorubicin taken 
as standards in Sarcoma 180 cells. Additionally, 
AEMC also exhibited a Cisplatin like oxidative da-
mage in mitochondrial superoxide dismutase and 
cytosolic catalase dificient Saccharomyces cerevisiae 
strains. Phytochemicals, present in AEMC fruit such 
as gallic, caffeic, chlorogenic and ellagic acid and 
flavonoid rutin may be responsible for the antitumo-
ral effects. Furtther researches are recommended 
to find out the responsible chemical moity(s) with 
the appropriate action mechanism(s) of our found 
activities. 
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